Table 7.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Pancreas After Kidney (PAK) Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		59	54	67	113	130	157	221	303	307	377
Tx With Follow-up Immunosuppression Info		37	42	49	88	105	128	198	263	274	317
Corticosteroids	Category Usage	43.2%	21.4%	83.7%	100.0%	100.0%	100.0%	99.5%	98.9%	98.2%	93.4%
	Steroids	43.2%	21.4%	83.7%	100.0%	100.0%	100.0%	99.5%	98.9%	98.2%	93.4%
Cyclosporine	Category Usage	100.0%	76.2%	61.2%	50.0%	21.0%	32.8%	16.2%	17.9%	15.0%	13.9%
	Cyclosporin	100.0%	76.2%	24.5%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	2.7%	0.0%	22.4%	9.1%	4.8%	4.7%	3.5%	4.2%	0.7%	0.9%
	Neoral	0.0%	0.0%	42.9%	42.0%	19.0%	29.7%	13.1%	14.1%	12.8%	11.0%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.1%	1.5%	3.2%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%
Tacrolimus	Category Usage	8.1%	45.2%	46.9%	63.6%	88.6%	76.6%	89.4%	89.7%	92.0%	88.0%
	FK506	8.1%	45.2%	46.9%	63.6%	88.6%	76.6%	89.4%	89.7%	92.0%	88.0%
Antimetabolites	Category Usage	100.0%	90.5%	95.9%	98.9%	96.2%	97.7%	93.9%	85.6%	79.6%	77.6%
	Azathioprine	100.0%	90.5%	65.3%	17.0%	8.6%	8.6%	7.1%	5.7%	2.6%	1.9%
	Mycophenolate mofetil	0.0%	2.4%	63.3%	88.6%	92.4%	94.5%	91.4%	83.3%	78.1%	76.7%
	Cytoxan	0.0%	0.0%	0.0%	1.1%	0.0%	0.8%	0.0%	0.0%	0.0%	0.3%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.8%	6.1%	23.6%	30.3%	31.9%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.8%	6.1%	23.6%	30.3%	31.9%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.